600918:SSEZhongtai Securities Co Ltd Class A Analysis
Data as of 2026-07-23 - not real-time
CN¥5.62
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Zhongtai Securities is trading at CNY 5.62, just above the calculated support of CNY 5.23 and well below its 200‑day SMA of CNY 6.26, indicating a long‑term downtrend. The short‑term technical picture is modestly positive – the 20‑day SMA (CNY 5.51) sits just above the 50‑day SMA (CNY 5.49), the MACD histogram is bullish and the RSI at 54 points to a neutral momentum zone, while volume is trending higher. Valuation metrics are mixed: the trailing P/E of 31.2 is almost double the industry average of 17.7, yet the price‑to‑book ratio of 0.99 suggests the stock is priced near its book value and the dividend yield of 0.89 % with a low payout ratio (13.9 %) appears sustainable given a cash pile of CNY 142 bn that comfortably exceeds total debt of CNY 97 bn. The DCF‑derived fair value of CNY 66.9 is an extreme outlier, likely reflecting model assumptions rather than market reality.
Risk‑adjusted returns are constrained by a high 30‑day volatility of 35.8 % and a very leveraged balance sheet (debt‑to‑equity ≈ 183 %). However, the stock’s beta of 0.30 signals low systematic risk and the increasing trading volume reduces liquidity concerns. In the near term the upside is limited to the resistance around CNY 5.83, while the long‑term narrative hinges on the company’s ability to convert its sizable cash reserves into higher earnings and improve its thin ROE of 3.7 %.
Risk‑adjusted returns are constrained by a high 30‑day volatility of 35.8 % and a very leveraged balance sheet (debt‑to‑equity ≈ 183 %). However, the stock’s beta of 0.30 signals low systematic risk and the increasing trading volume reduces liquidity concerns. In the near term the upside is limited to the resistance around CNY 5.83, while the long‑term narrative hinges on the company’s ability to convert its sizable cash reserves into higher earnings and improve its thin ROE of 3.7 %.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price hovering just above technical support
- Bullish MACD and neutral RSI suggest limited upside
- Increasing volume supports current price stability
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Valuation gap between high P/E and near‑book price
- High leverage and low ROE constrain earnings growth
- Sustained dividend with strong cash cushion
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Substantial cash surplus relative to debt
- Low beta indicating defensive profile
- Potential upside if earnings and ROE improve, aligning price with intrinsic value
Key Metrics & Analysis
Financial Health
Revenue Growth20.90%
Profit Margin13.07%
P/E Ratio31.2
ROE3.68%
ROA0.75%
Debt/Equity182.85
P/B Ratio1.0
Op. Cash FlowCN¥22.9B
Industry P/E17.7
Technical Analysis
TrendNeutral
RSI54.4
SupportCN¥5.23
ResistanceCN¥5.83
MA 20CN¥5.51
MA 50CN¥5.49
MA 200CN¥6.26
MACDBullish
VolumeIncreasing
Fear & Greed Index91.71
Valuation
Fair ValueCN¥66.92
GradeFair
TypeValue
Dividend Yield0.89%
Risk Assessment
Beta0.30
Volatility35.83%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.